Skip to content
Methodology
All entries for: Zulia Biotech Inc.
October 16, 2025
Zulia Biotech Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of Huntington’s disease
Disease Area:
Rare Diseases
Source
Scroll to Top
